Abstract
To the Editor,
I read with great interest the article by Kreouzi et al., “Lessons Learned from Blue Zones, Lifestyle Medicine Pillars and Beyond: An Update on the Contributions of Behavior and Genetics to Wellbeing and Longevity,” recently published in American Journal of Lifestyle Medicine. 1 The authors’ integrative approach, linking lifestyle medicine principles with insights from population genetics, provides valuable direction for health promotion and disease prevention. Nevertheless, several methodological aspects merit closer scrutiny to strengthen future investigations and practical translation.
Firstly, the article draws extensively on data from centenarian populations in Blue Zones. While these insights are valuable, the absence of adjustment for survivor bias may confound interpretation. Evidence from studies in regions like Nicoya and Sardinia suggests that only a subset of long-lived individuals carry favorable genetic variants, yet many achieve longevity through behavioral adaptation alone. 2 A stratified genetic analysis could delineate the relative contributions of modifiable vs non-modifiable factors more clearly.
Secondly, dietary assessments in the reviewed cohorts appear to rely on retrospective recall, which introduces risks of recall and misclassification bias. In contrast, trials such as PREDIMED employed validated dietary questionnaires coupled with objective biomarkers, leading to more robust inferences on the relationship between nutrition and longevity. 3 Future Blue Zone–inspired studies could benefit from incorporating similar tools to enhance validity.
Moreover, the treatment of physical activity across populations seems generalized. Notably, data from accelerometer-based studies in Okinawan elders emphasize the role of moderate-to-vigorous activity, not merely incidental movement. 4 Differentiating intensity and type of activity would offer more nuanced understanding of behavior–gene interactions.
Lastly, although the authors mention APOE polymorphisms, the role of gene–environment interplay is underexplored. Contemporary literature supports the concept that favorable lifestyle behaviors can mitigate genetic risk profiles. 5 Integrating polygenic risk scores alongside lifestyle assessments would enhance the translational impact of this work.
In summary, Kreouzi et al. make a commendable contribution, but future work would be strengthened by deeper attention to bias mitigation, validated measurement tools, and genetic–behavioral synergy. These refinements will be essential in informing scalable lifestyle interventions for healthy aging.
